Stockreport

Biodesix to Report Third Quarter 2024 Financial Results on November 1, 2024

Biodesix, Inc.  (BDSX) 
PDF LOUISVILLE, Colo.--(BUSINESS WIRE)--Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostic solutions company with a focus in lung disease, today announced that it will [Read more]